IdentificationGeneric Name(2S,3R)-2-[[4-(Tert-butylcarbamoyl)piperazine-1-carbonyl]amino]-6-(diaminomethylideneamino)-3-formylhexanoic acidDrugBank Accession NumberDB03417BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (2S,3R)-2-[[4-(Tert-butylcarbamoyl)piperazine-1-carbonyl]amino]-6-(diaminomethylideneamino)-3-formylhexanoic acid (DB03417)× CloseWeightAverage: 427.4985 Monoisotopic: 427.254317201 Chemical FormulaC18H33N7O5SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUTrypsin-1Not AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableClassificationNot classifiedAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyBVNQCAHTTOIOEK-STQMWFEESA-NInChIInChI=1S/C18H33N7O5/c1-18(2,3)23-17(30)25-9-7-24(8-10-25)16(29)22-13(14(27)28)12(11-26)5-4-6-21-15(19)20/h11-13H,4-10H2,1-3H3,(H,22,29)(H,23,30)(H,27,28)(H4,19,20,21)/t12-,13-/m0/s1IUPAC Name(2S,3R)-2-{[4-(tert-butylcarbamoyl)piperazine-1-carbonyl]amino}-6-[(diaminomethylidene)amino]-3-formylhexanoic acidSMILES[H]N([H])C(=NCCC[C@@H](C=O)[C@H](N([H])C(=O)N1CCN(CC1)C(=O)N([H])C(C)(C)C)C(O)=O)N([H])[H]ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound6323182PubChem Substance46509093ChemSpider4883305ZINCZINC000012503583PDBe Ligand169PDB Entries1rxpClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourcelogP-3.6ChemaxonpKa (Strongest Acidic)3.43ChemaxonpKa (Strongest Basic)11.57ChemaxonPhysiological Charge0ChemaxonHydrogen Acceptor Count8ChemaxonHydrogen Donor Count5ChemaxonPolar Surface Area183.45 Å2ChemaxonRotatable Bond Count9ChemaxonRefractivity109.01 m3·mol-1ChemaxonPolarizability44.39 Å3ChemaxonNumber of Rings1ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterNoChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption-0.7801Blood Brain Barrier-0.9701Caco-2 permeable-0.7064P-glycoprotein substrateSubstrate0.8869P-glycoprotein inhibitor INon-inhibitor0.8218P-glycoprotein inhibitor IINon-inhibitor0.9866Renal organic cation transporterNon-inhibitor0.8648CYP450 2C9 substrateNon-substrate0.802CYP450 2D6 substrateNon-substrate0.7541CYP450 3A4 substrateNon-substrate0.5978CYP450 1A2 substrateNon-inhibitor0.8459CYP450 2C9 inhibitorNon-inhibitor0.8457CYP450 2D6 inhibitorNon-inhibitor0.9232CYP450 2C19 inhibitorNon-inhibitor0.835CYP450 3A4 inhibitorNon-inhibitor0.9015CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity1.0Ames testNon AMES toxic0.6894CarcinogenicityNon-carcinogens0.8961BiodegradationNot ready biodegradable0.9919Rat acute toxicity2.5279 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9395hERG inhibition (predictor II)Non-inhibitor0.7553  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Trypsin-1KindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionSerine-type endopeptidase activitySpecific FunctionHas activity against the synthetic substrates Boc-Phe-Ser-Arg-Mec, Boc-Leu-Thr-Arg-Mec, Boc-Gln-Ala-Arg-Mec and Boc-Val-Pro-Arg-Mec. The single-chain form is more active than the two-chain form aga...Gene NamePRSS1Uniprot IDP07477Uniprot NameTrypsin-1Molecular Weight26557.88 DaReferencesOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article] Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article] Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52 